Leerink Partners Stick to Their Hold Rating for Allscripts
- ByInvesting.com-
Leerink Partners analyst Stephanie Davis reiterated a Hold rating on Allscripts (NASDAQ:MDRX) on Thursday, setting a price target of $19, which is approximately 25.83% above the...